手术流产与医源性早产对妊娠合并癌症患者生存的影响:一项基于人群的队列研究
该回顾性人群队列研究纳入加拿大艾伯塔省和安大略省2003–2016年18–50岁妊娠期确诊癌症者,评估手术流产或医源性早产是否与改善生存相关。在<20周确诊癌症的512例中,手术流产与全因死亡风险无显著关联(aHR=1.39,95%CI 0.32–6.17);在<37周确诊的782例中,医源性早产亦无显著关联(aHR=1.17,95%CI 0.76–1.81)。
要点
- 妊娠<20周确诊癌症者中,手术流产与全因死亡风险无显著关联(aHR=1.39,95%CI 0.32–6.17)。
- 妊娠<37周确诊癌症者中,医源性早产与全因死亡风险无显著关联(aHR=1.17,95%CI 0.76–1.81)。
- 作者认为这些产科干预是高度个人化的决定,应由妊娠者与照护提供者共同商议。
核心结论
- 手术流产或医源性早产均与妊娠合并癌症患者生存改善无关;但作者认为这些产科干预是高度个人化的决定,最好由妊娠者与照护提供者共同商议。
研究设计与样本
- 回顾性基于人群的队列研究,地点为加拿大艾伯塔省和安大略省,时间2003–2016年。
- 人群为18–50岁女性,分别于妊娠<20周(评估手术流产)或<37周(评估医源性早产)确诊癌症。
- 采用Cox比例风险模型评估全因死亡,调整癌症部位、诊断时分期和年龄;并用Meta分析合并两省结果。
主要发现
- 共有512例于妊娠<20周确诊癌症,782例于妊娠<37周确诊癌症。
- 调整年龄、诊断时分期和癌症部位后,手术流产与全因死亡风险无显著关联(aHR=1.39,95%CI 0.32–6.17)。
- 调整年龄、诊断时分期和癌症部位后,医源性早产与全因死亡风险无显著关联(aHR=1.17,95%CI 0.76–1.81)。
临床怎么用
- 作者认为手术流产和医源性早产是高度个人化的决定,最好由妊娠者与照护提供者共同商议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer. DESIGN: Retrospective population-based cohort study. SETTING: Provinces of Alberta and Ontario, Canada, 2003-2016. POPULATION: Females aged 18-50 years diagnosed with cancer at <20 weeks' (for the assessment of procedural-induced abortion) or <37 weeks' gestation (for the assessment of provider-initiated delivery). METHODS: Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces. MAIN OUTCOME MEASURES: All cause mortality. RESULTS: There were 512 pregnant people diagnosed with cancer at <20 weeks' gestation and 782 diagnosed with cancer at <37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32-6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76-1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site. CONCLUSIONS: Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.
引用
- Metcalfe A, Cairncross ZF, Ray JG, et al. Procedural abortion, provider-initiated preterm delivery and survival in pregnant people with cancer: A population-based cohort study. BJOG. 2024. PMID: 39169531. doi:10.1111/1471-0528.17937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。